My suspicion is Merchant have bailed, maybe some of of the outgoing board/supporters too, but less convinced about that. Keen to see RAN'S list for this month to see where it all sits.
Props to John Clarke for his efforts today, wouldn't have been all that easy to front up to the mob, even if some of the responses were slightly canned. We didn't get all the rumours squashed, but my take was that John and the team are just getting on with it, which is exactly the course of action we need at this point. I'm not as confident as some we'll see MT back, but genuinely hope to eat my words on this and am not in the loop, so pure speculationon my part!
ODD being approved is big news. Well done to everyone at PAA past and present that's assisted in getting MPL to this point.
I genuinely think the early approval took them by surprise and everyone may have thought they had a few more weeks to get settled and potentially finish appointing the new team before it dropped. Ah well.
Hope we all have a great weekend.
- Forums
- ASX - By Stock
- PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
My suspicion is Merchant have bailed, maybe some of of the...
-
- There are more pages in this discussion • 907 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $93.42M |
Open | High | Low | Value | Volume |
19.0¢ | 19.5¢ | 19.0¢ | $39.40K | 207.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 889962 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 8641 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 889962 | 0.185 |
8 | 336753 | 0.180 |
4 | 120797 | 0.175 |
5 | 159661 | 0.170 |
3 | 164000 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 19500 | 1 |
0.195 | 26548 | 3 |
0.200 | 107907 | 5 |
0.205 | 109808 | 2 |
0.210 | 107676 | 2 |
Last trade - 12.32pm 13/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online